Menu Back toLeveraging Pharma Intelligence Data and Statistical Modeling to Inform Project Strategies

DIA 2021 Global Annual Meeting


Leveraging Pharma Intelligence Data and Statistical Modeling to Inform Project Strategies

Session Chair(s)

Mark  Kryah, PMP

Mark Kryah, PMP

  • Executive Director/Program Team Leader
  • Ultragenyx Pharmaceutical, United States
This session will explore use of external intelligence data sources in advanced statistical modeling to inform program strategies and clinical designs. Case studies will be shared.
Learning Objective : Describe various external data sources that can be used for statistical modeling; Identify how to use statistical modeling approaches leveraging this external data; Discuss how statistical modeling can inform and influence project strategies and clinical designs.

Speaker(s)

Zhaoling  Meng, PhD, MS

Informing Drug Development via Landscape Modeling Using Pharma Intelligence Data

Zhaoling Meng, PhD, MS

  • AVP, Global Head of Clinical Modeling and Evidence Integration
  • Sanofi, United States
Shameer  Khader, PhD, MPH

Application of Advanced Modeling on Development Programs

Shameer Khader, PhD, MPH

  • Senior Director, Data Science and Artificial Intelligence
  • AstraZeneca, United States